Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVR NASDAQ:BVS NASDAQ:INMD NASDAQ:MGRM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$8.95-4.4%$9.00$2.85▼$11.06$911.12M1.651.42 million shs790,560 shsBVSBioventus$11.56-4.2%$9.80$5.81▼$12.30$1.01B0.65683,636 shs530,143 shsINMDInMode$14.92-1.5%$14.02$12.72▼$16.74$870.83M1.91808,195 shs601,208 shsMGRMMonogram Orthopaedics$6.00$5.93$2.32▼$6.43$243.79M0.68253,414 shsN/AThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-4.38%-9.78%-2.19%+42.29%+191.53%BVSBioventus-4.23%+0.61%+35.84%+9.47%+1,155,999,900.00%INMDInMode-1.52%+2.61%+10.93%+4.70%+1.22%MGRMMonogram Orthopaedics0.00%0.00%0.00%0.00%+2.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$8.95-4.4%$9.00$2.85▼$11.06$911.12M1.651.42 million shs790,560 shsBVSBioventus$11.56-4.2%$9.80$5.81▼$12.30$1.01B0.65683,636 shs530,143 shsINMDInMode$14.92-1.5%$14.02$12.72▼$16.74$870.83M1.91808,195 shs601,208 shsMGRMMonogram Orthopaedics$6.00$5.93$2.32▼$6.43$243.79M0.68253,414 shsN/AThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-4.38%-9.78%-2.19%+42.29%+191.53%BVSBioventus-4.23%+0.61%+35.84%+9.47%+1,155,999,900.00%INMDInMode-1.52%+2.61%+10.93%+4.70%+1.22%MGRMMonogram Orthopaedics0.00%0.00%0.00%0.00%+2.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 2.60Moderate Buy$16.0078.77% UpsideBVSBioventus 3.00Buy$14.7527.60% UpsideINMDInMode 2.00Hold$16.007.24% UpsideMGRMMonogram Orthopaedics 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest MGRM, AVR, BVS, and INMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$14.006/16/2026BVSBioventus Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.006/2/2026BVSBioventus Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)5/29/2026AVRAnteris Technologies Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/22/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$14.005/15/2026AVRAnteris Technologies Global BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$17.00 ➝ $18.005/7/2026INMDInMode BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$21.00 ➝ $19.005/7/2026INMDInMode Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$17.00 ➝ $14.00(Data available from 7/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$1.91M456.12N/AN/A($0.01) per share-895.00BVSBioventus$576.30M1.68$1.22 per share9.46$2.76 per share4.19INMDInMode$370.49M2.31$1.47 per share10.15$10.78 per share1.38MGRMMonogram OrthopaedicsN/AN/AN/AN/A$0.42 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$94.14M-$2.23N/AN/AN/A-5,148.78%-124.76%-101.21%8/10/2026 (Estimated)BVSBioventus$22.73M$0.4128.2012.991.544.94%29.97%9.52%N/AINMDInMode$93.83M$1.3610.97N/AN/A23.27%13.47%11.95%7/23/2026 (Estimated)MGRMMonogram Orthopaedics-$16.33M-$0.50N/AN/AN/AN/A-126.82%-96.87%N/ALatest MGRM, AVR, BVS, and INMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2026Q2 2026AVRAnteris Technologies Global-$0.2073N/AN/AN/A$1.50 millionN/A7/23/2026Q2 2026INMDInMode$0.3327N/AN/AN/A$93.03 millionN/A5/12/2026Q1 2026AVRAnteris Technologies Global-$0.2708-$0.28-$0.0092-$0.28$0.77 million$0.49 million5/6/2026Q1 2026BVSBioventus$0.09$0.15+$0.06$0.04N/A$132.09 million5/6/2026Q1 2026INMDInMode$0.2978$0.25-$0.0478$0.18$79.84 million$82.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ABVSBioventusN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A20.9320.93BVSBioventus1.081.691.13INMDInModeN/A8.807.88MGRMMonogram OrthopaedicsN/A2.162.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ABVSBioventus62.94%INMDInMode68.04%MGRMMonogram Orthopaedics0.45%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies Global4.50%BVSBioventus33.50%INMDInMode6.92%MGRMMonogram Orthopaedics28.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13897.34 million92.96 millionN/ABVSBioventus1,20083.54 million55.55 millionN/AINMDInMode48057.48 million53.50 millionOptionableMGRMMonogram Orthopaedics2840.63 million29.21 millionNot OptionableMGRM, AVR, BVS, and INMD HeadlinesRecent News About These CompaniesMonogram Technologies Inc. (MGRM) Shareholder/Analyst Call Prepared Remarks TranscriptSeptember 30, 2025 | seekingalpha.comMonogram Orthopaedics Faces Merger Review DelaySeptember 5, 2025 | tipranks.comMonogram Orthopaedics Delays 10-Q FilingAugust 15, 2025 | tipranks.comZimmer Biomet Announces Second Quarter 2025 Financial ResultsAugust 7, 2025 | prnewswire.comMonogram Orthopaedics Updates on Zimmer Biomet AcquisitionAugust 3, 2025 | theglobeandmail.comMonogram Orthopaedics Initiates Mandatory Stock ConversionAugust 3, 2025 | theglobeandmail.comMonogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement SurgeryJuly 31, 2025 | taiwannews.com.twTMonogram announces first autonomous saw-based robotic knee replacement procedureJuly 31, 2025 | massdevice.comMonogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement SurgeryJuly 29, 2025 | globenewswire.comMonogram Orthopaedics Announces Acquisition by Zimmer BiometJuly 29, 2025 | msn.comMONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRMJuly 16, 2025 | businesswire.comMonogram Orthopaedics Ends License Agreement with Mount SinaiJuly 14, 2025 | tipranks.comMGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer BiometJuly 14, 2025 | globenewswire.comMonogram Technologies stock soars after Zimmer Biomet acquisition dealJuly 14, 2025 | in.investing.comZimmer Biomet to buy Monogram for $177M in cashJuly 14, 2025 | msn.comZimmer Biomet to expand robotic suite with Monogram acquisitionJuly 14, 2025 | massdevice.comShareholder Alert: The Ademi Firm Investigates Whether Monogram Technologies Inc. is Obtaining a Fair Price for its Public ShareholdersJuly 14, 2025 | businesswire.comMGRM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Monogram Technologies Inc. Is Fair to ShareholdersJuly 14, 2025 | businesswire.comZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsJuly 14, 2025 | globenewswire.comZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsJuly 14, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGRM, AVR, BVS, and INMD Company DescriptionsAnteris Technologies Global NASDAQ:AVR$8.95 -0.41 (-4.38%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$8.96 +0.02 (+0.17%) As of 07/14/2026 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Bioventus NASDAQ:BVS$11.56 -0.51 (-4.23%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$11.56 0.00 (-0.01%) As of 07/14/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.InMode NASDAQ:INMD$14.92 -0.23 (-1.52%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$14.90 -0.02 (-0.10%) As of 07/14/2026 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Monogram Orthopaedics NASDAQ:MGRMMonogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet 3 Overlooked Energy ETFs Delivering Strong Returns and Income 3 Space Stocks That Could Outshine SpaceX After Its IPO 3 Energy Stocks Racing to Fix AI's Power Problem JPMorgan’s Q2 Strength Gives the Stock Rally New Support No Space For Panic: T-Mobile Shrugs Off The Starlink Threat Prepare for the Next Wave of Factory Automation With These 3 Standout Names Wedbush Pounds the Table—Buy Sandisk Before August 5 Earnings Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
